Close Menu

Myriad Genetics was handed a win a few weeks ago when a federal appeals court ruled in the company's favor and upheld its BRCA gene patents. However, the court also struck down Myriad's methods patents. So now, both sides — Myriad and the plaintiffs represented by the ACLU — are asking the court to review its decision, though for different reasons, says Genomics Law Report's John Conley.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Russia says its candidate SARS-CoV-2 vaccine has a very high efficacy rate in an initial analysis of clinical trial data, according to the Financial Times.

Wired reports on a microbial analysis of sketches drawn by Leonardo DaVinci.

A new survey explores coronavirus vaccine hesitancy among Black and Latino individuals, the Washington Post reports.

In Nucleic Acids Research this week: the Aging Atlas database, a database of human metagenome-related metadata, and more.